Green, M. L., Leisenring, W. M., Xie, H., Walter, R. B., Mielcarek, M., Sandmaier, B. M., . . . Boeckh, M. (2013). CMV reactivation after allogeneic HCT and relapse risk: Evidence for early protection in acute myeloid leukemia. American Society of Hematology.

Green, Margaret L., Wendy M. Leisenring, Hu Xie, Roland B. Walter, Marco Mielcarek, Brenda M. Sandmaier, Stanley R. Riddell, and Michael Boeckh. CMV Reactivation After Allogeneic HCT and Relapse Risk: Evidence for Early Protection in Acute Myeloid Leukemia. American Society of Hematology, 2013.

Green, Margaret L., et al. CMV Reactivation After Allogeneic HCT and Relapse Risk: Evidence for Early Protection in Acute Myeloid Leukemia. American Society of Hematology, 2013.